Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women

BMC Women's Health

Table 2 FSFI scores at baseline and after 8 weeks of treatment

	Testosterone N = 35	Placebo N = 35	p value^a
Pre-treatment FSFI score	18.5 ± 5.8	16.3 ± 7.0	0.17
Post-treatment FSFI score	28.6 ± 3.6	25.3 ± 6.7	0.04

Data are presented as mean ± SD; FSFI = Female Sexual Function Index
^aANCOVA was used to compare the FSFI scores between groups for post-treatment FSFI

ISSN: 1472-6874